Abstract
FIGS, Inc. will report quarterly results on November 5, 2026 Post-Mkt; this preview outlines consensus revenue and EPS expectations, last quarter’s margin and profit trajectory, core business drivers to watch, and the prevailing institutional stance into the print.Market Forecast
Consensus for the current quarter points to revenue of 182.70 million US dollars, up 28.19% year over year, with adjusted EPS estimated at 0.07, up 291.14% year over year; EBIT is projected at 15.82 million US dollars, up 339.43% year over year. No explicit guidance for gross profit margin or net profit margin was available in the dataset for the current quarter. The core medical scrubs line remains the commercial backbone, with solid product breadth and repeat purchase behavior providing support for unit volume and pricing discipline in the near term. The most promising adjacent category is non-medical workwear, which generated 35.39 million US dollars last quarter; year-over-year growth by sub-segment was not disclosed.Last Quarter Review
FIGS, Inc. delivered last quarter revenue of 196.62 million US dollars (up 28.81% year over year), a gross profit margin of 75.20%, GAAP net profit attributable to the parent company of 28.38 million US dollars, a net profit margin of 14.43%, and adjusted EPS of 0.11 (up 175.00% year over year). Quarter-on-quarter, net profit rebounded sharply, with net profit growth of 351.32%, underscoring the combination of high gross margin and improving operating efficiency. Within the revenue mix, medical scrubs contributed 161.23 million US dollars (82.00% of sales), while non-medical workwear contributed 35.39 million US dollars (18.00% of sales); year-over-year growth by sub-segment was not disclosed.Current Quarter Outlook
Core Medical Scrubs
The core medical scrubs franchise is expected to carry the quarter again given its scale, customer loyalty, and the brand’s cadence of product refreshes. With last quarter’s gross profit margin at 75.20%, the current quarter’s profitability profile will hinge on how promotional intensity compares with the prior year and whether average selling prices hold against unit growth. Sequentially, revenue is projected to step down from last quarter’s 196.62 million US dollars to 182.70 million US dollars, which places the focus on seasonality and inventory positioning rather than a demand slowdown year over year. Investors should monitor order growth, repeat-purchase ratios, return rates, and any commentary on new product adoption inside core scrubs, since these elements influence both top line and the sustainability of high contribution margins. A stable mix toward premium scrubs SKUs would support margin resilience, while any outsized promotional activity could compress gross margin even if volumes meet expectations.The operating expense trajectory will also be in focus. Last quarter’s adjusted EPS of 0.11 benefited from disciplined operating costs relative to rapid revenue expansion. For this quarter, consensus adjusted EPS of 0.07 implies that the company is expected to maintain profitability despite a sequential revenue step-down, a common dynamic for consumer-oriented companies with uneven quarterly seasonality. Execution against marketing efficiency and fulfillment costs will likely determine whether EPS lands at or above consensus, particularly given the high gross margin baseline that magnifies the impact of operating expense control.
Finally, inventory levels and the cadence of new arrivals within the scrubs assortment matter for sell-through and markdown risk. If inventory is aligned to demand and replenishment is timed to conversion peaks, FIGS, Inc. can protect its realized pricing while supporting order frequency. Conversely, a mismatch could necessitate incremental discounting, which would pressure margin even if unit volumes stay healthy.
Lifestyle and Non-Medical Workwear
The lifestyle and non-medical workwear category generated 35.39 million US dollars last quarter and remains a strategic lever for broadening the brand’s addressable customer base. While the dataset does not provide year-over-year growth for this sub-segment, the category’s contribution can enhance overall basket size if cross-selling from core scrubs is effective. The near-term question is whether demand in this adjacent segment can compound alongside the core without elevating return rates or dilution from heavier discounting; a favorable outcome would be reflected in both units and stable realized pricing within the quarter.Marketing mix and creative efficacy will be critical for this category. If the company can efficiently target cross-category buyers and convert them at acceptable acquisition costs, the profitability of non-medical workwear should remain accretive. Given last quarter’s net profit margin of 14.43%, the business has room to invest in customer acquisition where lifetime value justifies it, but the market will scrutinize whether spending remains disciplined to preserve margin. Watch for commentary on conversion rates, repeat behavior among lifestyle customers, and assortment breadth, as these will signal whether the category can sustain positive momentum into the holiday period.
Merchandising and sizing depth will also influence outcomes. A tight, data-driven assortment limits markdown exposure, supporting gross margin durability. The category’s success this quarter will be judged on incremental contribution to revenue and the maintenance of overall margin quality, especially if the company prioritizes profitable growth over maximizing short-term sales.
Key Stock Price Drivers This Quarter
Revenue relative to the 182.70 million US dollars consensus is the first major catalyst. The year-over-year hurdle of 28.19% sets a clear performance threshold; a beat here would validate demand resilience and likely reset expectations for the holiday quarter. Conversely, an in-line or modest miss would shift focus to gross margin, expense control, and inventory quality to gauge the durability of earnings into year-end.Gross margin stability is the second driver. With a 75.20% baseline last quarter, investors will closely track pricing integrity and promotional cadence. A gross margin result close to this baseline would suggest that mix, markdowns, and freight/fulfillment costs are well managed; any unexpected deterioration could overhang the stock even if revenue meets consensus. Management’s tone on promotion and inventory will be pivotal for interpreting margin trends.
Earnings power relative to the 0.07 adjusted EPS estimate is the third driver. Incremental operating efficiency, especially in marketing and logistics, can drop a meaningful share of gross profit to the bottom line, magnifying the impact on EPS. The market will also parse commentary for signals on active customer growth, order frequency, and average order value into the holiday period, as these metrics influence both revenue visibility and margin structure. Any update to full-quarter or fourth-quarter expectations would be a material swing factor for the shares.
Analyst Opinions
Bullish views dominate recent published opinions, outnumbering bearish calls by a wide margin. Among ratings within the reference period, Oppenheimer maintained an Outperform and raised its price target to 25 US dollars, underscoring confidence in sustained top-line momentum and high-margin execution. Barclays’ Adrienne Yih maintained a Buy rating, most recently citing a 20 US dollars price target; an earlier note in the period referenced a 17 US dollars target alongside a Buy stance, indicating growing conviction as execution improved. KeyBanc’s Ashley Owens also maintained a Buy with a 19 US dollars price target. Accounting for these updates, the ratio of bullish to bearish opinions skews decisively positive, with multiple buys and no contemporaneous sell ratings observed; one neutral/hold call from Telsey Advisory was noted but remains in the minority.What lifts the bullish case is the blend of growth and profitability visible in the recent print and the current consensus. Last quarter’s revenue of 196.62 million US dollars, 75.20% gross margin, and 14.43% net profit margin provide tangible evidence of a high-margin model. The current-quarter outlook calling for 182.70 million US dollars in revenue and 0.07 adjusted EPS, with year-over-year growth of 28.19% and 291.14% respectively, suggests a path to sustained earnings even against sequential seasonality. Bulls argue that the brand’s unit economics leave room to navigate promotional swings while protecting margin quality, and that marketing efficiency can support EPS leverage as the customer base expands.
Bullish analysts also highlight the durability of the demand profile and the company’s control over product development, which together can support product refreshes without materially compromising price. They point to EBIT forecast growth of 339.43% year over year to 15.82 million US dollars as a sign that operating leverage remains available even as the business reinvests, provided spending stays aligned with profitable growth. The combination of high gross margin, improving operating efficiency, and a manageable revenue hurdle has led institutions to raise or reiterate constructive targets into this quarter.
The bullish camp is attuned to potential risks but sees them as manageable within the model. If promotional activity were to increase, gross margin could come under pressure; however, bulls expect the company to calibrate discounting to demand and inventory, preserving margin integrity. Inventory positioning and product cadence are recognized as swing factors; still, the recent quarter’s net profit rebound and consensus EPS trajectory suggest that inventory management and fulfillment costs are under control. On balance, the institutional tone is that the company can meet or exceed the 28.19% year-over-year revenue growth bar while holding the line on margin, which underpins constructive price targets from firms such as Oppenheimer, Barclays, and KeyBanc.
In summary, the majority of recent institutional commentary favors a positive setup into November 5, 2026. The evidence cited includes a high gross margin baseline, a clear runway to achieve consensus revenue and EPS, and identifiable levers in marketing and operations that can deliver incremental earnings power. While a neutral stance exists, the current distribution of opinions is weighted toward the bullish side, and the key variables they emphasize—gross margin stability, operating expense discipline, and revenue versus the 182.70 million US dollars consensus—frame the core scorecard for the upcoming report.
Comments